Glyco’s Canadian Patent 2,896,038, has been issued

“GlycoBioSciences Inc. is pleased to announce, that after having its patents in the US issued/granted in 2017 and 2019, US Patents 9,821,005 and 10,322,142, that cover Glyco’s Ionic Polymer Matrix (IPM) topical delivery technology, and related products, that Glyco's Canadian Patent has been issued by the Canadian Intellectual Property Office (CIPO).

Read full statement here